- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT07916363
Active Release Technique vs. Dynamic Soft Tissue Mobilization for Plantar Pain
Comparison of Active Release Technique Versus Dynamic Soft Tissue Mobilization on Pain, Range of Motion, Functional Outcomes and Disability in Subjects With Plantar
Plantar fasciitis is one of the most common causes of heel pain encountered in musculoskeletal and orthopedic physiotherapy practice. It is characterized by degenerative changes at the origin of the plantar fascia on the medial calcaneal tubercle, leading to pain, stiffness, and functional limitations during weight-bearing activities. Patients typically report sharp heel pain that is most severe during the first steps in the morning or after prolonged rest, which significantly affects gait and daily functional activities.Current evidence suggests that plantar fasciitis is not purely an inflammatory condition but rather a degenerative fasciopathy resulting from repetitive microtrauma, abnormal foot biomechanics, prolonged standing, obesity, and tightness of the gastrosoleus complex. These mechanical stressors lead to microtears, collagen degeneration, and thickening of the plantar fascia, ultimately resulting in chronic pain and disability.Objective of this study is to compare the effectiveness of Active Release Technique and Dynamic Soft Tissue Mobilization on pain, function, and disability in patients with plantar fasciitis. All the subjects who will eligible for the criteria will randomly allocated in to Group A(ART) and Group B(DSTM).Taping will be our baseline treatment.. This study will be a randomized controlled trial conducted at Pro Care Physiotherapy Clinic, Ittefaq Hospital, and Iffat Anwar Medical Complex over a period of four months. A total of 62 participants will be recruited using probability convenient sampling and randomly allocated into two groups. Group A will receive Active Release Technique along with baseline taping, while Group B will receive Dynamic Soft Tissue Mobilization along with baseline taping. Both groups will receive three sessions per week for four weeks.Outcome measures will include the Numerical Pain Rating Scale (NPRS) and Foot Function Index (FFI) to assess pain and functional disability. Assessments will be taken at baseline, 2nd week, and 4th week. Data will be analyzed using SPSS version 24, and both intra-group and inter-group comparisons will be performed using appropriate statistical tests.
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Tipo de estudo
Inscrição (Real)
Estágio
- Não aplicável
Contactos e Locais
Locais de estudo
-
-
Punjab Province
-
Lahore, Punjab Province, Paquistão, 54000
- University of Management & Technology
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
Age 25 to 60 years. Presence of unilateral plantar fasciitis. Participants with positive Windlass test. Symptoms more than 6 weeks of duration diagnosed by orthopaedician. Reported pain with the first step out of the bed in the morning or with the first step after prolonged immobilization and presence of heel pain with prolonged standing on the medial calcaneal tubercle plantar aponeurosis confirmed by palpation. both male and female will be included. Pain intensity of ≥3 on the Visual Analog Scale (VAS) or Numeric Pain Rating Scale (NPRS).
Participants willing to provide informed consent and comply with the treatment protocol.
Exclusion Criteria:
Reported previous history of cancer, peripheral vascular diseases, lower extremity fractures Had a trauma or history of surgery to the foot or ankle. Diabetic neuropathy. People who have undergone steroid therapy, platelet rich plasma therapy in the past 3 months.
Severe foot deformities (e.g., severe pes planus or pes cavus) requiring specialized management.
Open wounds, skin infections, or allergies preventing the application of taping.
Presence of inflammatory or systemic diseases such as Rheumatoid Arthritis, Ankylosing Spondylitis, or Gout.
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Tratamento
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Solteiro
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: Active Release Technique (ART)
The patient will sit in a long-sitting position while the therapist assesses muscle and fascial tightness using their hands. The therapist applies specific pressure along the affected tissue from origin to insertion while the muscle is shortened. The patient is then instructed to lengthen the muscle by dorsiflexing the foot. Each session lasts approximately 10 minutes, three times a week for four weeks, along with baseline taping. |
The patient will sit in a long-sitting position while the therapist assesses muscle and fascial tightness using their hands. The therapist applies specific pressure along the affected tissue from origin to insertion while the muscle is shortened. The patient is then instructed to lengthen the muscle by dorsiflexing the foot. Each session lasts approximately 10 minutes, three times a week for four weeks, along with baseline taping. |
|
Comparador Ativo: Dynamic Soft Tissue Mobilization
The therapist will perform 10 minutes of deep, forceful soft tissue mobilization on tight and painful areas of the posterior calf muscles, applying pressure across the muscle fibers medially and laterally. The patient will also perform a passive straight leg raise combined with ankle dorsiflexion using a long belt to improve neural mobility. |
The therapist will perform 10 minutes of deep, forceful soft tissue mobilization on tight and painful areas of the posterior calf muscles, applying pressure across the muscle fibers medially and laterally. The patient will also perform a passive straight leg raise combined with ankle dorsiflexion using a long belt to improve neural mobility. |
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Pain by Numerical Rating Scale (NPRS)
Prazo: At baseline and after 6 weeks
|
Numeric Rating Scale (NPRS) is most frequently used instruments to measure pain. The 11-point numeric with 0 representing No pain, 1- 3 representing Mild Pain (nagging, annoying, interfering little with ADLs), 4-6 representing Moderate Pains (interferes significantly with ADLs), 7-10 representing Sever Pain (disabling, unable to perform ADLs). |
At baseline and after 6 weeks
|
|
Disability by Foot Function Index (FFI)
Prazo: At baseline and after 6 weeks
|
The Foot Function Index (FFI) is a widely used patient-reported outcome measure developed to assess the impact of foot pathology on pain, disability, and activity limitation.The questionnaire consists of 23 items divided into three subscales: Pain (9 items), Disability (9 items), and Activity Limitation (5 items). The questions assess foot pain severity and the extent to which foot problems affect daily functional activities such as walking, standing, climbing stairs, and participation in routine activities. |
At baseline and after 6 weeks
|
|
Joint Range of Motion by Goniometer
Prazo: At baseline and after 6 weeks
|
The patient's knee will be flexed to 30°, with the ankle in the anatomical position. The goniometer axis will be placed near the lateral ankle, with the stationary arm aligned along the fibula and the movable arm along the fifth metatarsal. The examiner will measure both passive and active ankle dorsiflexion using a goniometer. The normal range of ankle dorsiflexion is approximately 15°-20°. |
At baseline and after 6 weeks
|
Colaboradores e Investigadores
Patrocinador
Publicações e links úteis
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Estimado)
Conclusão do estudo (Estimado)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Outros números de identificação do estudo
- RE-207-2026
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Descrição do plano IPD
The results data collected , de-identified individual participant data will be shared.
Prazo de Compartilhamento de IPD
6 months after the publication of the manuscript.
Critérios de acesso de compartilhamento IPD
The data can be requested from the corresponding author.
Tipo de informação de suporte de compartilhamento de IPD
- PROTOCOLO DE ESTUDO
- SEIVA
- CIF
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .